Johnson & Johnson Analysts Raise Their Forecasts After Upbeat Earnings
1. JNJ beat earnings expectations, reporting $2.77 per share. 2. Sales increased 5.8% year over year to $23.74 billion. 3. Fiscal year 2025 guidance raised for earnings and sales. 4. Stock rose 6.2%, closing at $164.78 post-announcement. 5. Analysts revised price targets, with some maintaining 'Buy' ratings.